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Abstract
Background: Muscles get smaller and weaker as we age and become more vulnerable to atrophy when physical
activity is reduced or removed. This research is designed to investigate the potentially protective effects of two
separate exercise strategies against loss in skeletal muscle function and size, and other key indices of health,
following 14 days of reduced physical activity in older men.
Methods: Three groups of 10 older men (aged 65–80 years) will undertake 2 weeks of reduced activity by
decreasing daily steps from more than 3500 to less than 1500 (using pedometers to record step count). Two of
the three groups will then undertake additional exercise interventions, either: 4 weeks of progressive resistance
training prior to the step-reduction intervention (PT-group), or home-based ‘exercise snacking’ three times per day during
the step-reduction intervention (ES-group). The third group undertaking only the step-reduction intervention (control) will
provide a comparison against which to assess the effectiveness of the protective exercise strategies. Pre and post step-
reduction assessments of muscle function, standing balance, anthropometry and muscle architecture will be taken. Pre
and post step-reduction in postprandial metabolic control, resting systemic inflammation, adipose inflammation, oxidative
stress, immune function, sleep quality, dietary habits, and quality of life will be measured. The stress response to exercise,
and signalling protein and gene expression for muscle protein synthesis and breakdown following an acute bout of
exercise will also be assessed pre and post step-reduction. Rates of muscle protein synthesis and adipose triglyceride
turnover during the step-reduction intervention will be measured using stable isotope methodology. All participants will
then undertake 2 weeks of supervised resistance training with the aim of regaining any deficit from baseline in muscle
function and size.
Discussion: This study aims to identify exercise strategies that could be implemented to protect against loss of muscle
power during 2 weeks of reduced activity in older men, and to improve understanding of the way in which a short-term
reduction in physical activity impacts upon muscle function and health.
Trial registration: ClinicalTrials.gov: NCT02495727 (Initial registration: 25 June 2015)
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Background
The ageing process is accompanied by a progressive loss
of muscle size and strength, and data from longitudinal
studies suggests that muscle size is lost at 0.5–1 % per
year after the age of 50 [1]. With ageing, muscle strength
is lost two to five times more rapidly than would be
expected based on the rate of muscle mass loss [2], and
at twice the rate in the legs compared to the upper body
[3]. Muscle power is the product of force and velocity of
movement, and it is evident that power decreases with
age to an even greater extent than strength [4]. Power
provides an indication of the neuromuscular component
of muscle function and thus is considered to be a better
predictor of functional status than muscle mass or
strength alone [5, 6]. Frailty is largely caused by this loss
of muscle function [7, 8], eventually resulting in the
tasks of daily living becoming too physically strenuous
to be managed safely, and independent living becoming
untenable.
Physical activity has been shown to be vitally important
for maintaining muscle mass and function. During periods
of dramatically reduced activity, such as bed rest, the
muscles of healthy individuals rapidly lose size, strength
and power, most notably from the legs [9, 10], with
older individuals seemingly more vulnerable to this
complete ‘disuse-induced’ muscle atrophy than younger
individuals [11, 12]. In a population of generally healthy
older individuals, however, extended periods of bed rest
are unlikely to occur unless accompanied by severe in-
jury or illness that may cause muscle wasting independ-
ently. Periods of reduced activity in healthy older adults
are more likely to be the result of minor injury or ill-
ness, or extended bad weather [13, 14]. Scenarios such
as these would result in a reduction in the number of
steps walked on a daily basis for a short period of time,
rather than total bed rest. The only previous investiga-
tion to focus on this step-reduction model of reduced
physical activity in older people without any protective
interventions demonstrated that reducing walking to
less than 1500 steps per day for 2 weeks resulted in an
average loss of around 4 % of leg muscle tissue, but
with some participants losing up to 9 % [15]. In light of
the estimated annual loss of 0.5–1 % of muscle size this
much larger loss due to step-reduction is a concerning
observation, particularly with periods of reduced activ-
ity occurring more often in older age [13]. However, in
the aforementioned study, muscle strength was not
reduced by the period of step-reduction, which is sur-
prising given that strength is typically lost more rapidly
than muscle size [16]. It should be noted that muscle
strength was measured by assessing unilateral isometric
knee extensor torque using a dynamometer for which
extensive familiarisation has been demonstrated to be
crucial to obtain reliable results [17]. Furthermore,
changes in muscle power cannot be inferred from isomet-
ric dynamometry. Given that the nervous system is shown
to adapt to changes in physical activity levels more rapidly
than the contractile structures of muscle tissue [18],
muscle power may be more sensitive to periods of reduced
activity than maximum-force-producing capabilities. An
additional and critically important role of the neuromuscu-
lar system is to maintain postural balance. If the neuro-
muscular system is compromised after a period of reduced
activity it could be hypothesised that balance would be af-
fected leading to an increased risk of falling [19, 20].
With only two studies previously investigating this topic
specifically in an older population [15, 21], many ques-
tions remain as to the precise physiological mechanisms
causing such marked response in muscle tissue to a seem-
ingly benign and common scenario [22]. Although there is
a wealth of literature highlighting the importance of main-
taining physical activity for many elements of healthy age-
ing [23], relatively little direct evidence exists regarding
the impact of acutely reducing activity in already healthy
individuals. The physiological responses occurring when
physical activity levels change are not confined to single
tissues or organs [24], and it is crucial to understand the
interactions between tissues that result in negative health
outcomes such as muscle loss, particularly in an older
population. Gaining an understanding of the impact of
short-term reductions in physical activity is also a crucial
precursory step to identifying protective interventions
with real-world applicability. Resistance exercise is widely
regarded to be the primary countermeasure against ‘dis-
use-induced’ muscle wasting [10, 25, 26]. In circumstances
in which a period of reduced activity is scheduled but
physical activity will subsequently be limited, for example,
following to minor elective surgery, physical preparation
through a concentrated period of resistance training may
raise the ‘baseline’ muscle function and health profile such
that reduced activity-induced muscle loss is compensated
for. This may present a strategy to improve recovery from
reduced activity as performance tasks of daily living
should be no more challenging than prior to the pre-
training, thus potentially allowing return to previous
habitual activity levels more quickly.
There may of course be circumstances in which reduced
activity is unavoidable but capacity to exercise is not com-
promised, for example, during extended inclement wea-
ther. Devries et al. [21] demonstrated that laboratory-based
low-load resistance thrice weekly in fact increased leg lean
tissue in older men during 2 weeks of step-reduction to
less than 1500 steps/day. However, restricted access to
resistance exercise equipment may render this exercise
strategy infeasible; thus, home-based, body weight exercise
may be a practical alternative to low-load resistance train-
ing. Previously, other health indices (e.g. metabolic health
and mobility in frail older people) have been demonstrated
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to be improved by such exercise regimes [27, 28]. Again,
this presents an opportunity to prevent decline in muscle
function due to periods of reduced physical activity that
may contribute to frailty, increased risk of falls, and their
associated negative implications.
Study objectives
The primary aim is to determine the protective effects
of two exercise interventions against the loss of lower
limb skeletal muscle power in healthy men aged 65–80
years undertaking 14 days of reduced physical activity
(less than 1500 steps per day). The two exercise inter-
ventions are either: (1) undertaking 4 weeks of resist-
ance training prior to the 14 days of step-reduction, or
(2) home-based ‘exercise snacking’ during the 14 days
of step-reduction. Alongside this, the influence of the
step-reduction intervention and potential protective ef-
fects of the exercise interventions on other indices of
muscle function (strength and neural drive), standing
balance, anthropometric measures, metabolic health,
rate of muscle protein and adipose triglyceride synthe-
sis during ‘free-living’, markers of inflammation and
oxidative stress at rest and in response to exercise, im-
mune function (e.g. lymphocyte cytokine production),
dietary habits, sleep quality and quality of life will be
assessed. Thereafter, the possible benefits of the exer-
cise interventions on recovery of muscle function and
size will be investigated. Once all elements of the study
are completed, the acceptability of the interventions
and feasibility of adhering to the approaches of the
recommended exercise strategies will be assessed, and
user-generated input for improvements to future
follow-on work obtained.
Study design
The methods described herein have been approved by
the National Health Service (NHS) South West Cornwall
and Plymouth Research Ethics Committee (REC) with
an allocated REC reference number: 15/SW/0130. The
project was subsequently registered as a clinical trial
(ClinicalTrials.gov: NCT02495727). The Standard Proto-
col Items: Recommendations for Interventional Trials
(SPIRIT) checklist was completed.
The study will address the objectives by way of a three-
group randomised control trial. One group will act as a
‘control’ against which to compare the potential protective
effects of exercise interventions insofar as this group will
undertake step-reduction without either exercise interven-
tion. Hypotheses: (1) reduced activity alone will result in
loss of leg muscle power, (2) exercise pre-training will in-
crease leg muscle power above baseline so any loss of
muscle power due to the reduced activity period will be
offset to such an extent that muscle power will remain
above pre-training baseline, and (3) daily exercise snacking
during the reduced activity period will attenuate the de-
cline in leg muscle power due to reduced activity.
Methods
Recruitment
The study will be advertised on the University of Bath
web pages, and on posters placed around the University
of Bath campus and distributed to local community
clubs for older people in the Bath area. A press release
will be sent to local newspapers and radio and television
media outlining the study objectives and it is expected
that interviews will be carried out as a result to raise
awareness of the study.
Inclusion criteria
In order to participate in this study, volunteers must sat-
isfy all of the following criteria:
 Be aged 65 to 80 years
 Not be underweight or obese (body mass index
(BMI) ≥20 and ≤30 kg/m2)
 Be a non-smoker (for more than 5 years)
Exclusion criteria
Participants will not be able to take part in this study if
they meet any one of the following criteria:
 Have any chronic illness, cardiac, pulmonary,
liver, or kidney abnormalities, uncontrolled
hypertension, peripheral arterial disease, insulin-
or non-insulin dependent diabetes or other
metabolic disorders
 Are individuals who consume on a daily basis any
analgesic or anti-inflammatory drug(s), prescription
or non-prescription
 Are individuals taking medications known to affect
protein metabolism (i.e. corticosteroids, non-
steroidal anti-inflammatory drugs, or prescription-
strength acne medications)
 Are individuals with a history of bone, joint or
neuromuscular problems or a current
musculoskeletal injury
 Are individuals with a known bleeding disorder, take
the anticoagulant drug warfarin, or are prone to
keloid scarring
 Are individuals with a known negative reaction to
the local anaesthetic lidocaine
 Are individuals with any joint replacement surgical
implants or other artefacts containing metal
 Are individuals who completed fewer than 3500
steps per day (as assessed by pedometer) prior to
the study
 Are individuals who score less than 8 on the Short
Physical Performance Battery [29]
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Population and sample size
Thirty healthy men (non-smokers without diabetes) aged
65–80 years will be recruited and randomised into three
groups of 10 by way of minimisation to limit between
group differences in mean age, BMI and habitual steps/
day. Participant and researcher blinding to group allocation
is not possible, and screening and group allocation will be
implement by the same researcher for all participants
The study is powered to detect the protective effect of
the aforementioned exercise strategies against loss of leg
muscle power during 14 days of reduced activity. Over
14 days of step-reduction a mean (SD) decrease of 3.9
(2.4 %) in lower limb muscle mass is anticipated [15],
with measures of muscle power expected to decline at a
similar or faster rate; thus, seven participants per group
(95 % power and 5 % alpha) will be required to observe
changes in leg muscle strength. The decline in muscle
power is expected to be the same in the pre-training
group as in the control group, hence significant in-
creases in leg muscle power prior to reducing physical
activity are required. Significant increases in leg strength
in older men with 4 weeks of pre-training could be ob-
served using nine participants (95 % power and 5 %
alpha) [30], and it expected that this would be equivalent
in muscle power. It is difficult to predict the extent of
the protective effect likely to be provided by the exercise
snacking. Therefore, the sample size will be rounded to
10 participants per group to account for drop out and
the potentially more subtle changes that might be
observed in the secondary measures.
Overview of study procedures
See Fig. 1 for a flow diagram of the study protocol. Fol-
lowing baseline assessment of habitual steps/day, to en-
sure familiarity with functional measures, all participants
will attend two familiarisation sessions. Participants in
the step-reduction intervention (PT-group) will then
undertake 4 weeks of resistance exercise training. All
participants will undertake a main trial the day before
commencing 14 days of reduced activity by step-
reduction to less than 1500 steps per day. On days 3 and
8 of the step-reduction protocol, a resting muscle biopsy
sample will be taken. The day after the step-reduction
period, a follow-up main trial will be conducted as per
the first main trial, followed 3 days later by a final rest-
ing muscle biopsy. All participants will undertake
2 weeks of laboratory-based resistance re-training and a
final assessment of leg muscle function and anthro-
pometry, with the option of a follow-up qualitative
interview of their experience of the trial. Thereafter, all
participants will be offered a 3-month membership to
the University of Bath Sports Training Village gym,
gym classes, and swimming pool, and a personalised
feedback sheet of their own data presented in lay terms.
Preliminary screening
During an initial telephone contact initiated by potential
participants, a member of the study team will provide a
verbal overview of the study, and ask if the participant
believes that they meet all of the inclusion criteria and
none of the exclusion criteria. Those who are interested
in participating will be sent information about the study
requirements in writing. Interested participants will be
asked to sign an informed consent form stating their
willingness to undergo an eligibility screening with a
member of the research team to ensure that participants
do not exhibit any physiological condition that either
poses undue personal risk or introduces bias into the ex-
periment. During this screening, participants will under-
take an objective assessment of physical function (Short
Physical Performance Battery (SPPB) [29]). Only partici-
pants scoring over 7 out of 12 without scoring 0 on any
element of the SPPB will be eligible to participate. Balance
scales and a stadiometer will be used to determine the
participant’s weight and height, recorded on inhalation of
breath with the head positioned in the Frankfort plane
position. BMI will subsequently be calculated. Participants
will then be provided with a pedometer (CW600 Digi-
Walker, Yamax, Tokyo, Japan) and instructed in its use, a
physical activity monitor BodyMedia armband (Sensewear
Professional 8.0, Pittsburg, PA, USA) and dietary record
sheets. Participants will be asked to wear the pedometer
and the BodyMedia armband for 7 days and to weigh and
record all food and drink consumed for 3 days (including
one weekend day) using a diet record sheet. The pedom-
eter will record the daily step count and the reset step
count at midnight each day. Only individuals who average
3500 steps per day or above will be invited to take part
in the rest of the study, and at this point one of the in-
vestigators will describe the study verbally to them again
and provide the opportunity for potential participants
to gain clarification on any aspect of the study. Eligible
participants will be randomly allocated to an experi-
mental group by minimisation to limit difference in
mean age, steps/day and BMI at baseline between
groups. All further details of the elements of the study
specific to the group will be provided. Written informed
consent will be acquired at this stage in regard to each
participant’s understanding and willingness to take part
in the rest of the study after group allocation. The inves-
tigator will also explain to the participants that they are
completely free to withdraw from the study at any time
without any repercussions.
Familiarisation sessions
Participants will be asked to wear light clothes in which it
is comfortable to perform exercise, and be given a thor-
ough demonstration of all balance and strength tests,
which they will then attempt.
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Balance tests will assess postural sway with the partici-
pants’ eyes open and closed with them standing as still
as possible on a force-measuring platform (AccuGait,
AMTI, Watertown, MA, USA) with their feet side-by-
side and heels 15 cm apart for 40 s, or feet together for
60 s. Participants will then practice the standard Y-
balance test of single-leg balance [31], involving pushing
their non-standing leg as far as they can forward, behind
and to the right, and behind and to the left, whilst main-
taining balance on the standing leg.
Leg strength assessments will be conducted on a pneu-
matic leg press machine (A420, Keiser®, Fresno, CA,
USA), instrumented to measure the force applied to the
foot pedals with the velocity the pedals moved at 400 Hz.
Following a standardised warm-up, participants will
complete one repetition maximum (1RM) tests on the leg
press for single repetitions up to the greatest resistance at
which one repetition can be completed, with self-selected
rest and increments in force between repetitions. Deter-
mination of 1RM is commonly used in adult popula-
tions [32–34] and is considered safe [35], valid and
reproducible [36] in older populations. Following a re-
covery period of at least 5 min, the participants will then
practice the incremental power test on the leg press that
Fig. 1 A flow diagram of the study timeline. SPPB, Short Physical Performance Battery; BMI, bodymass index; PT-Group, pre-training group;
ES-Group, exercise snacking group
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will be used in the main trials. In this test, participants
will complete approximately 10 discrete repetitions of
the leg press exercise, with the movement in each repe-
tition performed as quickly as possible. The resistance
will increase in each successive repetition, starting with
very low resistance up to approximately the previously
achieved 1RM, with increasing recovery periods between
repetitions. Participants will then be asked to repeat a
similar familiarisation and 1RM test on a pneumatic knee
extension machine.
Finally, participants’ ability to generate their maximum
possible force (i.e. neural drive) will be examined by
maximal voluntary isometric calf muscle contractions,
with concomitant surface-evoked twitch stimulation to
produce maximal stimulated force. The participant will
be seated on a custom-built device, with the ankle dorsi-
flexed to 10° and the knee braced at 90° against a strain
gauge to measure the force of isometric contraction of
the plantar-flexor muscles. Stimulating electrodes will be
attached to the skin surface of the calf muscle region,
with the cathode and anode placed on the upper and
lower thirds of the triceps surae respectively. Stimulation
will be delivered with a DS7 stimulator (Digitimer,
Letchworth Garden City, UK). Initially, the force of a
maximum voluntary plantar-flexor contraction will then
be obtained, followed by a maximum evoked from single
twitches at rest. Thereafter, the participant will make
three repeated attempts to match the previously ob-
tained maximum voluntary force with a pulse of elec-
trical stimulation (of the same voltage previously
identified to evoke maximal twitch force) passed across
the calf muscle to maximally stimulate the muscle at the
point of maximum force. The difference between the
maximum voluntary force and maximum twitch-evoked
force will indicate the participant’s ability to maximally
stimulate their muscle [37].
Main trials
The main trials will take place the day before the 14-day
step-reduction (day 0) and the day after (day 15) (see
Fig. 1). See Fig. 2 for schematic overview of the main
trial day timeline.
Participants will be asked to report to the laboratory
after a 10-hour overnight fast, wearing lightweight cloth-
ing with no metal components. Balance scales and a
stadiometer will be used to determine the participant’s
weight and height for calculation of BMI. A whole body
dual-energy X-ray absorptiometry scan (DXA (Discov-
ery; Hologic, Bedford, UK)) and a peripheral quantitative
computed tomography scan ((pQCT) (XCT 3000 scan-
ner; Stratec, Pforzheim, Germany)) of the calf (66 % tibia
length) and thigh (25 and 50 % femur length) will be
performed. An ultrasound scan of the medial gastrocne-
mius and vastus lateralis muscles will be conducted
whilst standing to examine fascicle length and pennation
angle (Echoblaster 128EXT-1Z, Revision C, and LV7.5/
60/96z Transducer, LS128 CEXT, both TELEMED,
Vilnius, Lithuania). The pQCT and ultrasound will be
taken from the dominant leg. Subsequently, participants
will complete five self-paced walks of 5 m whilst being
filmed at 200 Hz with one camera in the sagittal plane
to assess lower limb gait coordination.
A resting venous blood sample via cannula, followed
by a biopsy sample of subcutaneous adipose tissue by
needle aspiration, from approximately 5 cm lateral to
the umbilicus, will be obtained after 15 min of seated/
supine rest. Participants will then ingest a 200-ml dose
of D2O water and undertake a mixed-meal tolerance
test (mixed-macronutrient liquid meal of 2 g/kg BM
carbohydrate; 0.8 g/kg BM fat; 0.4 g/kg BM protein)
with 5-ml blood samples taken 15, 30, 45, 60, 90, 120,
150 and 180 min after consumption of the drink.
Thereafter, a muscle biopsy will be sampled using the
Fig. 2 A schematic overview of the main trial data collection day; arrows indicate the timing of blood,adipose and muscle samples
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Bergstrom needle biopsy technique adapted for use
with suction [38] from the vastus lateralis muscle. Con-
secutive muscle biopsies will be taken proximal to the
previous biopsy site [39].
Participants will then undertake the balance testing as
performed in the familiarisation procedure. The standard
leg pressing warm-up will then be performed using the
previously obtained 1RM, and the incremental power
test as a measure of leg power will be undertaken. Fol-
lowing 2 min of recovery, participants will complete the
assessment of neural drive of the calf muscle, followed
by three sets of eight repetitions at 70 % 1RM on the leg
press and leg extension (total of 48 repetitions). There
will be 2 min of recovery between sets. Blood samples
will be taken immediately on completion of exercise,
and a muscle biopsy obtained from the contralateral leg
after 90 min of rest. Whilst the participant rests, they will
be asked to complete two questionnaires (The Pittsburgh
Sleep Quality Index [40] and the World Health Organisa-
tion Quality of Life-BREF (WHOQOL-BREF) [41]).
Step-reduction intervention
For 14 days participants will be asked to restrict their daily
step count to 1500 steps per day. A portable pedometer
will be worn by participants at all times throughout the
day (excluding sleep) to allow accurate monitoring and
feedback of step count. Step count will be recorded each
day by the participant in a provided log-book. The pedom-
eter will also automatically record daily step count, and
will reset at midnight. An advice sheet will be provided to
suggest strategies to reduce daily stepping. Participants
will also wear a BodyMedia armband for the first 7 days of
step-reduction. They will be asked to record their dietary
intake on the first, seventh and 13th days of the step-
reduction intervention using a dietary record sheet. For
the two visits to the laboratory during the step-reduction
period, transport arrangements will be made to minimise
walking for the participant for the sake of the visits (i.e.
door-to-door transport, transport within the facility/cam-
pus by wheelchair).
Further assessments
On the third day of the 14-day step-reduction (day 3), par-
ticipants will be asked to return to the laboratory for a
blood sample and resting muscle biopsy. Participants in
the exercise snacking group (ES-group) will be asked to
perform an exercise snack in the laboratory. This will be
repeated on the eighth day of the 14-day step-reduction
(day 8), and 100 ml D2O water will be ingested.
Three days after the 14-day step-reduction (day 18),
participants will be asked to return to the laboratory
for a final resting blood sample and muscle biopsy to
be taken.
Exercise interventions
Pre-training group (PT)
The PT-group will attend 10 resistance training sessions
across 4 weeks prior to the 14-day step-reduction, with
sessions separated by at least 48 hours arranged at the
participant’s convenience. The last training session will
take place at least 3 but less than 7 days before the first
main trial prior to step-reduction. All exercise sessions
will be fully supervised by a member of the research
team. Participants will complete the standardised warm-
up on the Keiser leg press as performed during the fa-
miliarisation session. All training sessions will begin with
leg press and leg extension, then alternate between two
sessions (A and B) to incorporate variation into the
programme (see Table 1). At the beginning of the fifth
session, participants will repeat the 1RM and incremen-
tal power tests so exercise resistances can be adjusted to
strength gains accordingly. Repetitions will be performed
at a cadence of 1:1 for concentric-eccentric time, at a
comfortable participant-selected pace that should be less
than 5 s per complete repetition. Rest intervals between
sets will be 90 to 120 s at the participant’s discretion.
Exercise snacking regime
The exercise snacking requires only a stable kitchen
chair to perform it, and no supervision is necessary. Par-
ticipants will be asked to perform five exercises, each for
1 min followed by 1 min of rest. In that minute of exer-
cise, the participant will perform as many controlled
repetitions of the given exercise as possible. Participants
will be asked to perform the exercise snacks three times
daily at least 2 hours apart. The exercises are: sit-to-
stand from a chair, seated alternating knee extension,
standing alternating knee bends holding onto a chair,
marching on the spot, and standing calf raises. Partici-
pants will always perform the sit-to-stand exercise first,
and record the number of repetitions completed within
1 min, and thereafter participants may alternate the
order of exercises, but will be asked to record the order
in a log-book provided. Participants will be asked to rec-
ord in the log book the number of steps taken immedi-
ately prior to, and after, each exercise snacking bout so
as to not count the steps incurred for each exercise
snack towards the 1500 steps/day limit.
Re-training
Participants will attend six resistance training sessions
after the step-reduction, with the first training session
taking place on the day of follow-up biopsy 3 once the
sample has been taken. The remaining five sessions will
take place over 14 days with sessions separated by at least
48 hours. These sessions will follow the same training re-
gime as the PT-group undertook prior to commencing
Perkin et al. Trials  (2016) 17:381 Page 7 of 11
the step-reduction. Resistances for the exercises during re-
training will be based on the data from the main trial post
step-reduction.
Post re-training muscle size, strength and power
assessments
Follow-up assessments of muscle function, balance, and
muscle size and architecture will be made 2 days after the
final session of the 2-week laboratory-based re-training.
This assessment will include repetition of the DXA, pQCT
and ultrasound scans, and the leg press incremental power
test, test of neural drive, and standing balance.
Acceptability and feasibility of adopting prescribed
training regimes
Following the 2-week re-training period participants will be
invited to take part in an interview to provide feedback on
their experience during the trial to inform the feasibility
assessment of each exercise regime. Participants will be
provided with written information of the purpose of the
interviews following their final re-training session, and reas-
sured that participation is optional. Interviews will take
place via telephone or in person according to participant
preference, will be digitally recorded, transcribed verbatim
and anonymised on completion. The interview schedule
will include: (1) participants’ perceptions of the impact of
inactivity on mood, appetite, vitality, sleep and other
participant-generated concerns (for comparison across con-
ditions), and (2) perceived barriers and facilitators and costs
and benefits to adherence to the study protocol (i.e. if and
how participants adapted the prescribed regimes, and fac-
tors they suggest would make the protocol easier to adopt).
Sample processing and storage
Adipose and muscle tissue samples will be processed
and analysed immediately on the day of collection or
stored at −80 °C for later batch analysis. Blood collected
into an ethylenediaminetetraacetic acid (EDTA) tube
(2 ml) will be used to provide a full leukocyte differential
and other standard haematology variables with an auto-
mated haematology analyser (SF-300, Sysmex Ltd.,
Milton Keynes, UK). Other blood samples collected into
EDTA and plain tubes (5 ml) will be centrifuged to
obtain plasma and serum, respectively. Blood collected
into a sodium heparin tube (25 ml) will be used to iso-
late peripheral blood mononuclear cells. All samples will
be stored at −80 °C for later batch analysis.
Potential harms
An inherent risk associated with this study is the potential
for loss in lean tissue and muscle function for participants;
however, the graduated exercise re-training programme
will aim to fully restore decrements in muscle size and
function. Moreover, all exercise sessions and testing will
be supervised by study staff with appropriate training. The
blood and tissue sampling techniques used in the present
study also carry a risk of discomfort to the participant;
however, all study staff are fully trained, experienced, and
adhere to best practice at all times to minimise this risk.
All tissue sampling procedures will be performed in sterile
conditions, and participants will be provided with exten-
sive advice on aftercare of biopsy sites to minimise risk of
infection. Any adverse events will be recorded, assessed,
and monitored by the University of Bath sponsorship in
the form of 6-monthly progress reports. All potential risks
have been reported to, assessed, and approved by the
study sponsor, Research Ethics Approval Committee for
Health (University of Bath), and the Cornwall and
Plymouth NHS Research Ethics Committee. Any modifi-
cations to the protocol will be approved by all aforemen-
tioned parties.
Data analyses
Primary outcome measure
Differences in leg power from pre- to post-step-reduction
intervention and differences between groups.
Secondary outcome measures
Differences from pre to post step-reduction within and
between groups in (1) leg muscle size, (2) muscle fas-
cicle length and pennation angle, (3) body composition,
(4) standing balance ability, (5) distances reached on
the Y-balance test, (6) coordination variability in walk-
ing, (7) neural drive to muscle, (8) postprandial area
Table 1 Training session content and progression
Exercise Sessions 1 and 2 Session 3–10
Session A Session B Sets Reps Load Sets Reps Load
Seated leg press 3 8 60 % 1RM 4 8 75 % 1RM
Seated leg extension
DB calf raise DB lat raise 2 10 70 % 10RM 3 10 80 % 10RM
DB bicep curl and press RB seated row
1RM maximum load at which a single repetition can be completed, 10RM maximum load at which 10 repetitions can be completed, DB dumbbells, Lat lateral
plane of motion, RB elastic resistance band, Reps repetitions
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under the curve of circulating insulin, triglyceride, and
postprandial high-density lipoprotein (HDL), low-
density lipoprotein (LDL) and non-esterified fatty acid
(NEFA) concentrations, (9) rates of muscle protein and
adipose triglyceride synthesis at rest over 14 days as
assessed by D2O incorporation into muscle protein and
glycerol in adipose, respectively, (10) total and phosphory-
lated muscle protein synthesis (protein kinase B (AKT),
mechanistic target of rapamycin (mTOR), 70-kDa riboso-
mal protein S6 kinase 1 (P70S6K), 4E binding protein 1
(4EBP-1)) and breakdown (muscle RING-finger protein-1
(MuRF-1), muscle atrophy F-box (MAFbx), forkhead box
(FOXO)) of signalling proteins within the muscle, (11)
muscle heat shock protein (HSP)27 content before and
after exercise, (12) subcutaneous adipose tissue cytokine
secretion and gene expression (e.g. leptin, adiponectin,
interleukin (IL)-6, tumour necrosis factor (TNF)α, IL-8,
IL-1ra) (13) systemic cytokines at rest (e.g. IL-6, TNFα,
C-reactive protein (CRP)), (14) mitochondrial function
at rest (e.g. H2O2 and aconitase activity), and (15) T-
lymphocyte interferon-γ production following stimula-
tion with proteins from common viruses (e.g. adeno-
virus, influenza, Varicella zoster virus, cytomegalovirus,
Epstein-Barr virus).
There is no intention to terminate the trial based on any
interim results collected, and thus no data monitoring
committee is deemed necessary. No ancillary data analysis
is anticipated. Only study staff will have access to the trial
dataset until all future manuscripts containing results are
written, and only in anonymised format. Authorship eligi-
bility will be addressed on completion of data analysis.
Acceptability and feasibility
Interview transcripts will be analysed systematically
using framework analysis to highlight key themes within
and across participants relevant to the acceptability of
the two intervention protocols, and the feasibility of
wider implementation.
Statistical analyses
Repeated measures analysis of variance (ANOVA) with
appropriate post-hoc tests adjusted for multiple compar-
isons will examine changes over time in the key variables
measured in muscle (e.g. HSP content, total muscle pro-
tein synthesis, phosphorylation of muscle protein, syn-
thesis and breakdown of signalling proteins, etc.) and
blood samples (e.g. inflammatory variables, biomarkers
of metabolic health). Paired t tests will be employed to
test for differences in body composition variables,
strength and power, neural drive to muscle, balance, adi-
pose tissue cytokine secretion and insulin sensitivity pre
versus post interventions. Correlation coefficients will
also be calculated between transcription factor activation
and phosphorylation of signalling proteins. Statistical
significance will be accepted at P <0.05. Effect sizes will
also be calculated according to Cohen [42], with d >0.08
considered a large effect. Magnitude-based inferences
will also be calculated to examine the effect of the exer-
cise strategies on all variables of interest.
Discussion
This study aims to evaluate the effectiveness of two exercise
strategies to attenuate the effects of 2 weeks of reduced ac-
tivity on muscle power and other key health indices that
are known to be affected by changes in physical activity
level. Based on the previous studies, specifically implement-
ing a daily step-reduction in older individuals [15, 21], it is
expected that 14 days of reduced physical activity without
protective interventions will have a significant physiological
effect, with reductions in both muscle mass and insulin
sensitivity. These changes, however, are reversible and par-
ticipants will undergo re-training and assessments of
muscle size and function will be made to ensure partici-
pants have returned to baseline (i.e. pre step-reduction).
The step-reduction model and the exercise interventions
incorporated into this study have been selected specifically
because of their real-world applicability and high ecological
validity. It is hoped that the exercise interventions will pro-
vide a proof of principle that even relatively modest exercise
interventions may be effective countermeasures against re-
duced activity-induced muscle atrophy and decline in other
health indices, and that these intervention can be further
developed and optimised in future work. Given the limited
previous literature using a reduced-activity model in older
individuals it is hoped that inclusion of qualitative feasibility
analysis may draw out questions of interest that may not
have been previously considered, as well as considerations
to improve future work in this field.
Study limitations
The findings of the present study will be inherently lim-
ited in applicability due to the inclusion of only healthy,
non-smoking, non-obese, non-frail men, and the exclusion
of more common clinical phenotypes for this age group.
Moreover, the findings will hold limited generalisability to
older individuals taking regular anti-inflammatory medica-
tion and to older women. A further limitation is that this
study will not be able to inform on recovery from reduced
activity when simply returning to habitual activity levels
due to inclusion of the exercise re-training for all groups.
It is also not possible to draw conclusions on the efficacy
of the pre- and re-training programmes in altering any
markers of health measured from tissue or blood samples,
some of which may provide evidence as the mechanisms
of change at the whole body level.
Trial status
Participant recruitment for this study is ongoing.
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